Advanced search
Publication Cover
Cancer Investigation Volume 24, 2006 - Issue 3
Submit an article Journal homepage
479
Views
16
CrossRef citations to date
0
Altmetric
BRIEF CLINICAL REPORT

Alteration of Pemetrexed Excretion in the Presence of Acute Renal Failure and Effusions: Presentation of a Case and Review of the Literature

Johann C. Brandes Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA; Department of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland, USA
, M.D., Ph.D.,
Stuart A. Grossman Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA
, M.D. &
Homaa Ahmad Department of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland, USA
, M.D.
Pages 283-287 | Published online: 11 Jun 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nicole Hagner & Markus Joerger. (2010) Cancer chemotherapy: targeting folic acid synthesis. Cancer Management and Research 2, pages 293-301.
Read now

Articles from other publishers (15)

SABINE KARAM, VICTORIA GUTGARTS & ILYA GLEZERMAN. 2020. Onco-Nephrology. Onco-Nephrology 183 196.e7 .
R. Donald Harvey & Fadlo R. Khuri. 2018. The American Cancer Society's Principles of Oncology. The American Cancer Society's Principles of Oncology 220 235 .
Maureen Assayag, Philippe Rouvier, Marion Gauthier, Ghania Costel, Philippe Cluzel, Lucile Mercadal, Gilbert Deray & Corinne Isnard Bagnis. (2017) Renal failure during chemotherapy: renal biopsy for assessing subacute nephrotoxicity of pemetrexed. BMC Cancer 17:1.
Crossref
Jeffrey CrawfordPaul Wheatley-PriceJosephine Louella Feliciano. (2016) Treatment of Lung Cancer in Medically Compromised Patients. American Society of Clinical Oncology Educational Book:36, pages e484-e491.
Crossref
C. Corbaux, J. Marie, J.-P. Meraud, S. Lacroix, J.-Y. Delhoume, T. Jouary & S. Madoui. (2015) Sclérose cutanée des deux membres inférieurs sous pemetrexed. Annales de Dermatologie et de Vénéréologie 142:2, pages 115-120.
Crossref
A.-C. Toffart, S. Belaiche, D. Moro-Sibilot, S. Couraud & L. Sakhri. (2014) Impact des traitements utilisés en oncologie thoracique sur la fonction rénale. Revue des Maladies Respiratoires 31:10, pages 1003-1012.
Crossref
Bercin Kutluk Cenik, Han Sun & David E. Gerber. (2013) Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancer. Lung Cancer 80:3, pages 326-332.
Crossref
Yujia Wen, Eric R. Gamazon, Wasim K. Bleibel, Claudia Wing, Shuangli Mi, Bridget E. McIlwee, Shannon M. Delaney, Shiwei Duan, Hae Kyung Im & M. Eileen Dolan. (2012) An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers. Human Molecular Genetics 21:7, pages 1470-1480.
Crossref
Andreas Hochstrasser, Gabriel Benz, Markus Joerger, Arnoud Templeton, Martin Brutsche & Martin Früh. (2012) Interstitial Pneumonitis after Treatment with Pemetrexed: A Rare Event?. Chemotherapy 58:1, pages 84-88.
Crossref
Magalys Vitiello, Paolo Romanelli & Francisco A. Kerdel. (2011) Painful generalized erythematous patches: A severe and unusual cutaneous reaction to pemetrexed. Journal of the American Academy of Dermatology 65:1, pages 243-244.
Crossref
Nicolas J. Dickgreber, Jens Benn Sorensen, Luis G. Paz-Ares, Tine Kjestrup Schytte, Jane E. Latz, Karen B. Schneck, Zheng Yuan & José Miguel Sanchez-Torres. (2010) Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid. Clinical Cancer Research 16:10, pages 2872-2880.
Crossref
H A Burris. (2009) Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs. Oncogene 28:S1, pages S4-S13.
Crossref
Michael D Peake. (2009) Pemetrexed in the treatment of malignant pleural mesothelioma. Therapy 6:4, pages 569-575.
Crossref
Thomas E. Stinchcombe & Mark A. Socinski. (2008) Considerations for Second-Line Therapy of Non-Small Cell Lung Cancer. The Oncologist 13:S1, pages 28-36.
Crossref
Alan Boddy, Melanie Griffin, Sarah Knowles, Mojca Persic, Ian Scott, Julie Errington & Gareth Veal. (2007) Dosing of Cancer Patients with Low or Absent Renal Function. Therapies 62:2, pages 117-120.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.